Different indications and approval to market. Different names for, umm, clarity in the marketplace. Same generic if/when they’re released. I would think this would be way easier than biologics as it’s not that big.

As I said above, they ran it through some amount of clinical trials and got approval to mention it directly. Same drug matter, possibly the same formulations.